No. Seriously. Specifically, in regards to the cardiac divisions, which is most of the company revenue. Boston Sci is a sinking ship. They used to be an innovator back in the day, but have fallen too far behind. All of this re-aligning, power up bullshit, is simply ways for leadership to try and cut more and more costs. When you are company that does not innovate and bring solid products to market in a timely fashion, this is the only way to operate. There is a RIF going right now. What happens when they are behind the # at the end of the year? They will have another rif. It WILL happen. Ray Elliott wants to try and get the stock to around $10-12, then pray that someone will purchase the company.
Sinking ship. Use them for a job if you have to, but if you have any chances, go somewhere else.